Invivyd IVVD
NASDAQ IVVD
$0.86 +0.01 (+1.09%)
As of: Sep 30, 2026 · 3:01 PM EDT

Invivyd (IVVD) EBITDA Margin (2024 - 2025)

Updated

Invivyd (IVVD) posted EBITDA Margin of -72.10% for Q4 2025, up 59.20 percentage points from -131.30% a year earlier and up 10.73 percentage points from the prior quarter.

Analysis

Invivyd (IVVD) EBITDA Margin (2024 - 2025) Analysis & Trends

For FY2025, Invivyd's EBITDA Margin came in at -102.58%, up 588.44 percentage points from FY2024.

  • In prior years, Invivyd's EBITDA Margin was -691.03% in FY2024.
  • On a year-over-year basis, EBITDA Margin has increased in each of the last three quarters.
  • According to Business Quant data, EBITDA Margin for the three prior quarters was -82.82% (Q3 2025), -126.50% (Q2 2025) and -146.99% (Q1 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 35.95%
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 49.01%
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 6.02%
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn -
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn 33.11%
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 46.01%
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn -124.26%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 39.16%
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 39.10%
10 Invivyd 250.54 Mn -256.10 Mn 13.01 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -72.10%
Sep 30, 2025 -82.82%
Jun 30, 2025 -126.50%
Mar 31, 2025 -146.99%
Dec 31, 2024 -131.30%
Sep 30, 2024 -668.59%
Jun 30, 2024 -2,169.57%
API Access

Invivyd EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=IVVD&period=max&api_key=YOUR_API_KEY